Cancer Genetics and Epigenetics

Epigenetics deals with the study of heritable changes in gene, that does not include changes to the basic DNA arrangement — an adjustment in phenotype without an adjustment in genotype — which influences how cells read the genes.  The study of epigenetic modifications to the Cancer cells genome is called Cancer Epigenetics, that does not bring a change in the nucleotide sequence.

Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics.

A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.
During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutations. Their manipulation brings a great promising approach to for preventing, detecting and treatment of cancer

  • Heritable changes in gene
  • DNA arrangement
  • Nucleotide sequence

Related Conference of Cancer Genetics and Epigenetics

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Cancer Genetics and Epigenetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in